Loading ....
Coenza
Mokslininkų g. 12, Vilnius, Vilnius, 08412, Lithuania
Introduction
Coenza™ is a biotechnology brand launched in 2024 by Essential Phosphates Ltd., a Lithuanian company founded in 2017 with an initial focus on anticancer drug research. Headquartered in Vilnius, Lithuania, and supported by a U.S. distribution center in Bolingbrook, Illinois, Coenza was established to address the growing global demand for high-purity, well-characterized Coenzyme A (CoA) derivatives and phosphate-based compounds. The company’s team of 19 scientists, including five PhD-level researchers, brings extensive expertise in complex molecule development, process optimization, and custom synthesis, ensuring both innovation and reliability in their offerings.Company Background
Essential Phosphates Ltd. began as a research-focused enterprise with expertise in developing complex molecules for pharmaceutical applications. Recognizing a significant market gap for quality CoA derivatives, the company launched Coenza in 2024 as a specialized division dedicated to this field. The Coenza team includes 19 scientists, five of whom hold PhDs, and brings together a wealth of expertise in complex molecule design, process optimization, and scalable synthesis. This scientific depth enables Coenza to deliver consistent, high-quality products while also driving innovation in new compound development.Product Portfolio
Coenza offers an extensive catalog of more than 70 CoA derivatives, featuring a wide variety of structural modifications and salt forms. These compounds are available in both small laboratory quantities and bulk commercial volumes, making them suitable for research, manufacturing, and diagnostic applications. In addition to its core CoA product line, Coenza is actively expanding its portfolio to include nucleoside analogs and phosphoramidites. This diversification allows the company to meet a broader range of customer needs across multiple disciplines in the life sciences.Browse Full Product Range --->
Services & Capabilities
Coenza provides comprehensive custom synthesis services, from tailored molecule design to the development of synthetic routes and scale-up production. These services can deliver quantities ranging from milligrams for R&D purposes to large-scale commercial batches, with typical project timelines averaging six to eight weeks. The company also offers flexible custom packaging options to accommodate specific customer requirements, from small 10 mg vials to large, kit-ready configurations. For organizations seeking bulk supply or private-label solutions, Coenza supports OEM production with full traceability, regulatory documentation, and branding flexibility.
Request a Custom Synthesis Quote ---->
|
 |
 |
Locations & LogisticsCoenza’s primary research, manufacturing, and warehouse facilities are located in Vilnius, Lithuania, providing strategic access to European markets and compliance with EU regulations. Complementing this is the company’s distribution center in Bolingbrook, Illinois, which serves the United States and Canadian markets. This dual-location approach not only speeds up delivery times—often within three business days in core markets—but also strengthens Coenza’s capacity to respond quickly to customer demand. |
Mission & ValuesCoenza’s mission is to provide consistent, high-purity phosphate-based compounds that empower life science research and diagnostics. The company’s values are rooted in product quality, with a commitment to achieving purity levels of 95% or higher across all offerings. Coenza prioritizes strong customer relationships, open communication, and strategic adaptability to meet diverse project requirements. Fast product access and continuous improvement, supported by responsive after-sales service, form the foundation of its approach to customer satisfaction. |
 |
 |
|
